What the Allergist Needs to Know about Monoclonal Antibody Therapy
What the Allergist Needs to Know about Monoclonal Antibody Therapy is organized by American College of Allergy, Asthma & Immunology (ACAAI) and will be held from Aug 31, 2021 - Aug 30, 2024.
Target Audience: Allergists/Immunologists
Description: This webinar addresses key information that allergists need to know regarding the FDA Emergency Use Authorization of monoclonal antibodies in the treatment of COVID-19.
Learning Objectives:
• Apply the most current FDA guidelines for the use of monoclonal antibodies.
• Describe the mechanisms and current data
• Evaluate their COVID-19 patients using the High-Risk Criteria for appropriate use of monoclonal antibody therapy
• Describe benefits and risks and special considerations of these therapies and procedures to refer for administration
